Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of…
Biotechnology
US, Carlsbad [HQ]
Financials
Analysts
Wall Street · Earnings · Institutional SentimentA comprehensive analysis section that covers unveiling insights about Ionis Pharmaceuticals, Inc.'s gradings, price targets and earnings estimates. None
All monetary values are presented in USD ($). E stands for Estimate.
| FY | EPS | Revenue [mil.] | Profit [mil.] | EBITDA [mil.] | EBIT [mil.] | Expenses · SGA [mil.] | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E | E | E | E | E | E | |||||||
| 2014 | -0.5500 | -0.350 | 147 | 144 | -60 | 228 | -51 | -37 | -235 | 42 | 14 | 77 |
| 2015 | -0.3300 | -0.662 | 214 | 281 | -38 | -78 | -27 | -30 | -289 | -65 | 20 | 36 |
| 2016 | -0.7400 | -1.046 | 283 | 288 | -88 | -27 | -55 | 63 | -398 | 52 | 37 | 94 |
| 2017 | -0.7200 | -0.052 | 346 | 456 | -86 | -4 | -46 | 54 | -390 | 37 | 48 | 132 |
| 2018 | -0.0481 | -0.392 | 507 | 576 | -5 | 13,249 | 20 | -150 | -350 | 351 | 108 | 175 |
| 2019 | 2.0700 | 1.678 | 599 | 1,029 | 273 | 253 | -61 | 348 | -61 | 250 | 244 | 387 |
| 2020 | 2.1000 | -0.521 | 1,123 | 712 | 294 | -257 | 366 | -62 | 366 | -145 | 287 | 252 |
| 2021 | -3.4900 | -1.447 | 729 | 650 | -487 | 390 | -172 | 414 | -172 | 382 | 354 | 220 |
| 2022 | -0.2100 | -2.490 | 810 | 583 | -29 | 303 | -21 | 333 | -30 | 309 | 186 | 230 |
| 2023 | -1.9000 | -3.252 | 587 | 637 | -270 | -365 | -561 | 339 | -411 | 312 | 151 | 270 |
| 2024 | -2.5600 | -3.589 | 787 | 621 | -366 | -513 | -322 | -161 | -353 | -177 | 232 | 189 |
| 2025 | - | -3.427 | - | 733 | - | -579 | - | -190 | - | -209 | - | 223 |
| 2026 | - | 2.F12X/td> | - | 2.F12X/td> | - | 2.F12X/td> | - | 2.F121/td> | - | 2.F121 | - | 2.F121 |
| 2027 | - | 1.F13X/td> | - | 1.F13X/td> | - | 1.F13X/td> | - | 1.F131/td> | - | 1.F131 | - | 1.F131 |
| 2028 | - | 0.F14X/td> | - | 0.F14X/td> | - | 0.F14X/td> | - | 0.F141/td> | - | 0.F141 | - | 0.F141 |